When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MDNA - Medicenna Therapeutics names Kevin Moulder chief scientific officer
Medicenna Therapeutics Corp.
Medicenna Therapeutics (MDNA) announces the appointment of Kevin Moulder as the company’s chief scientific officer.Moulder brings over 30 years of experience in drug discovery and development in the fields of protein design, antibody technology, immuno-oncology, inflammation and autoimmune disease.He has served in research and development leadership positions in 9 international biotechnology companies including Biogen where he ran a predictive medicine department.